Autologous incubated macrophage therapy in acute, complete spinal cord injury: results of the phase 2 randomized controlled multicenter trial.
about
Spinal cord injury: how can we improve the classification and quantification of its severity and prognosis?Common data elements for spinal cord injury clinical research: a National Institute for Neurological Disorders and Stroke projectEmerging therapies for acute traumatic spinal cord injuryDealing with Danger in the CNS: The Response of the Immune System to Injury.Minimizing errors in acute traumatic spinal cord injury trials by acknowledging the heterogeneity of spinal cord anatomy and injury severity: an observational Canadian cohort analysisNeutrophil contribution to spinal cord injury and repair.Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice.An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-β yields a dominant immunosuppressive phenotype.Protection and Repair After Spinal Cord Injury: Accomplishments and Future Directions.Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study.Autoregressive transitional ordinal model to test for treatment effect in neurological trials with complex endpoints.Bridging the lesion-engineering a permissive substrate for nerve regenerationImmunomodulatory approaches to CNS injury: extracellular matrix and exosomes from extracellular matrix conditioned macrophages.Monitoring Upper Limb Recovery after Cervical Spinal Cord Injury: Insights beyond Assessment ScoresIdentification of distinct monocyte phenotypes and correlation with circulating cytokine profiles in acute response to spinal cord injury: a pilot study.Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'.Clinical translation of autologous Schwann cell transplantation for the treatment of spinal cord injury.Cellular therapeutics delivery to the spinal cord: technical considerations for clinical application.Targeting monocyte and macrophage subpopulations for immunotherapy: a patent review (2009 - 2013).Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia.Improving the therapeutic efficacy of neural progenitor cell transplantation following spinal cord injury.Toward Inclusive Trial Protocols in Heterogeneous Neurological Disorders: Prediction-Based Stratification of Participants With Incomplete Cervical Spinal Cord Injury.Identifying Homogeneous Subgroups in Neurological Disorders: Unbiased Recursive Partitioning in Cervical Complete Spinal Cord Injury.Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis.Neural precursor cell transplantation enhances functional recovery and reduces astrogliosis in bilateral compressive/contusive cervical spinal cord injury.Clinical trials in spinal cord injury: lessons learned on the path to translation. The 2011 International Spinal Cord Society Sir Ludwig Guttmann Lecture.Clinical experience with autologous M2 macrophages in children with severe cerebral palsy.Pulse article: How do you do the international standards for neurological classification of SCI anorectal exam?Stem cells for spinal cord injuries bearing translational potential.The anorectal exam is unnecessary!Magnetic Resonance Imaging-Guided Transplantation of Neural Stem Cells into the Porcine Spinal Cord.Safety and Therapeutic Potential of M2 Macrophages in Stroke Treatment.Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges.Innate Immunity in the CNS - A Focus on the Myeloid CellLocal inhibition of matrix metalloproteinases reduced M2 macrophage activity and impeded recovery in spinal cord transected rats after treatment with fibroblast growth factor-1 and nerve grafts
P2860
Q26827953-A6923749-F9AC-4A73-971A-46D3FD4552BDQ27008030-F2F4F382-2299-47D2-AFCF-B161616C7BADQ27022007-E6102FC7-272E-401F-8B78-88E744D4DC88Q30279070-B478800D-AE54-4B98-93D9-2DB3B89ECEE5Q34164217-3F514F82-8F96-4E1E-8DE9-2E2FE299531EQ34240286-A8A07174-6AE5-4E5F-B891-906A4AB36AC0Q34540968-0A285D21-218F-4ED5-AFF3-6B38DFDF81A4Q34805818-89686C6F-0296-4F58-BEDB-5D8AB001BE7CQ36054971-E5A794B1-7264-41BA-A949-52E775849FD8Q36131170-7C461293-22B8-472F-813D-2A5B106927D9Q36184576-C3D9107C-C183-4265-B7E0-01D67D5C8A5FQ36345120-445BDE0F-7F45-4538-A41F-888432CC1912Q36911680-D76C4DE0-2D71-466D-A0CF-50A29C3D40D1Q37218431-E68906BB-A8E9-4245-AC6A-CCEB705DA03BQ37708958-8922A717-127B-4A86-8E74-BD3EE766AA7DQ38046114-12353BCB-5B10-49F6-AC5B-BBEBF179AEC0Q38162020-FE85FA34-646D-4CC6-8B65-A4EEED3459DDQ38162491-357F7973-C098-45FB-B924-77EDCC10D549Q38207732-E68A2F74-3FA6-4338-A730-4C2CB1969730Q38283108-30347C79-2B42-4F15-9839-1465A739CA64Q39031796-835BA656-9A8A-4097-807A-FD0D9CE35397Q39044154-A13DDFE8-A6FD-41AE-8260-1835FB4B57B5Q39260621-ED311AAD-9B75-4912-9DE5-399D4AC0D442Q41519742-58FA9FA7-F784-4C65-9990-8432323644BDQ41905129-4D082239-F16C-4E25-A445-7F85EDB673A7Q43863012-1BFC6AD1-E1B3-48E1-99FA-EC454CE5BC3EQ44033387-A7B5E975-1976-47AD-80D6-7EAD16CB8704Q48501489-6CAABF86-9491-4B3C-9BE5-47C6801860E9Q49940089-D902DC58-552D-4F15-BFFA-1D5B0950C8A6Q50104867-8D10A9FD-30EA-450A-A7FF-5FC55738E873Q50187803-7328BC35-7766-461A-B6C9-59827BD875C4Q50951125-794237E6-8E3C-44F8-AB21-43181B07CE2FQ53476373-F87A9EC8-4604-413B-8DB1-02CD7A8A789DQ57599442-A9CAEA1C-82FC-499C-89E9-346E40943F5FQ58805397-304BDD80-5E7B-4DFA-8933-D9F7F385856E
P2860
Autologous incubated macrophage therapy in acute, complete spinal cord injury: results of the phase 2 randomized controlled multicenter trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Autologous incubated macrophag ...... controlled multicenter trial.
@en
Autologous incubated macrophag ...... controlled multicenter trial.
@nl
type
label
Autologous incubated macrophag ...... controlled multicenter trial.
@en
Autologous incubated macrophag ...... controlled multicenter trial.
@nl
prefLabel
Autologous incubated macrophag ...... controlled multicenter trial.
@en
Autologous incubated macrophag ...... controlled multicenter trial.
@nl
P2093
P356
P1433
P1476
Autologous incubated macrophag ...... d controlled multicenter trial
@en
P2093
A L Jenkins
D A Snyder
J P Cuthbert
K T Ragnarsson
L A T Jones
P2888
P304
P356
10.1038/SC.2012.39
P50
P577
2012-04-24T00:00:00Z